Evercore  announced that Ravi Mehrotra has joined Evercore ISI's Healthcare Research team as a Senior Managing Director. Dr. Mehrotra joins Senior Analysts Umer Raffat and Josh Schimmer, enabling continued expansion of coverage of the Biopharma sector. Dr. Mehrotra brings over two decades of Healthcare equity research and investment banking experience to the Evercore ISI platform. He was most recently a partner at MTS Health Partners, and prior to that he spent 11 years at Credit Suisse as an Analyst and head of their global Biotechnology research team.  During his time at Credit Suisse, Dr. Mehrotra was ranked the number one Biotechnology Analyst in both Institutional Investor and Extel surveys.  Prior to Credit Suisse, Dr. Mehrotra was Head of European Biotechnology Equity Research at SG Cowen and a Pharmaceuticals Equity Analyst at Deutsche Bank.